4-Hydroxypropranolol-d7(Synonyms: (±)-4-Hydroxy Propranolol-d7)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
4-Hydroxypropranolol-d7 (Synonyms: (±)-4-Hydroxy Propranolol-d7)

4-Hydroxypropranolol-d7 ((±)-4-Hydroxy Propranolol-d7) 是 4-Hydroxypropranolol hydrochloride 的氘代物。4-Hydroxypropranolol hydrochloride 是 Propranolol 的活性代谢产物。4-Hydroxypropranolol hydrochloride 的效力与 Propranolol 相当。4-Hydroxypropranolol hydrochloride 抑制 β1-和 β2-肾上腺素能受体，pA2 值分别为 8.24 和 8.26。4-Hydroxypropranolol hydrochloride 具有固有的拟交感活性，膜稳定活性和强效的抗氧化性能。

4-Hydroxypropranolol-d7(Synonyms: (±)-4-Hydroxy Propranolol-d7)

4-Hydroxypropranolol-d7 Chemical Structure

CAS No. : 1219908-86-7

规格 价格 是否有货
1 mg ￥4500 询问价格 & 货期
5 mg ￥15000 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

4-Hydroxypropranolol-d7 ((±)-4-Hydroxy Propranolol-d7) is the deuterium labeled 4-Hydroxypropranolol hydrochloride. 4-Hydroxypropranolol hydrochlorid is an active metabolite of Propranolol. 4-Hydroxypropranolol hydrochlorid is of comparable potency to Propranolol. 4-Hydroxypropranolol hydrochlorid inhibits β1- and β2-adrenergic receptors with pA2 values of 8.24 and 8.26, respectively. 4-Hydroxypropranolol hydrochlorid has intrinsic sympathomimetic activity, membrane stabilizing activity and potent antioxidant properties[1][2][3].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

282.39

Formula

C16H14D7NO3
CAS 号

1219908-86-7
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Fitzgerald JD, et al. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol. Br J Pharmacol. 1971 Sep;43(1):222-35.

    [3]. Nelson WL, et al. The 3,4-catechol derivative of propranolol, a minor dihydroxylated metabolite. J Med Chem. 1984 Jul;27(7):857-61.

    [4]. Ivan Tong Mak, et al. Potent Antioxidant Properties of 4-Hydroxyl-propranolol. Journal of Pharmacology and Experimental Therapeutics. 2004, 308(1):85-90.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务